SymBiosis focuses on advancing biotherapeutics innovations for serious and life‑threatening diseases, investing in groundbreaking medicines across disease areas, financing stages, and geographies, emphasizing programs in or approaching human trials.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
56.0%United Kingdom
8.0%Australia
4.0%Philippines
4.0%France
4.0%Other
8.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Symbiosis II LLC
Vintage 2021 • $182.3M
Symbiosis LLC
Vintage 2021 • $72.4M